Safety Study for the Use of Rapamycin in Children With Familial Adenomatous Polyposis

Summary

The hypothesize of this research is that rapamycin is effective and well-tolerated in teenagers with familial adenomatous polyposis (FAP). Rapamycin could be effective in blocking the formation of adenomas and/or their evolution by decreasing their size and number. Researchers aim to assess the safety profile of rapamycin in FAP adolescents using a 2 low dose regimen.

Timeline

Start

2026-09-01

Primary completion

2030-09

Completion

2030-09

Drugs

Indications